Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed Nov 2, 2012 · 10-Q · 33 days after period end · 0001193125-12-449319
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $12.53M | $13.05M | $12.19M |
| Net Income | $1.87M | $1.85M | $1.01M |
| EPS Diluted | $0.10 | $0.09 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 2, 2012 · 33 d after period end
